California Public Employees Retirement System’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
Other funds holding CCCC
PA
RI
BCLSI
ACH
WA
RCM
California Public Employees Retirement System's CCCC Position: Q2 2021 in Review
California Public Employees Retirement System sold out of C4 Therapeutics (CCCC) in Q2 2021, closing a stake of 19,490 shares — an estimated $721K sold.
California Public Employees Retirement System first reported a position in CCCC in Q4 2020 and held it in 2 quarters. The position peaked at $721K in Q1 2021. 107 funds tracked by Wall St. Rank hold CCCC as of Q2 2021.
- California Public Employees Retirement System reported no remaining C4 Therapeutics position as of Q2 2021 after selling out during the quarter.
- California Public Employees Retirement System sold 19,490 C4 Therapeutics shares in Q2 2021, an estimated $721K.
- California Public Employees Retirement System first reported a position in C4 Therapeutics in Q4 2020 and held it in 2 quarters.
- California Public Employees Retirement System's C4 Therapeutics position peaked at $721K in Q1 2021.
- 107 funds tracked by Wall St. Rank held C4 Therapeutics as of Q2 2021.
Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.